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Clinical Isolates of the Spain14-5 Clone of Streptococcus pneumoniae Carry a
Recombinant rpoB Gene
A characterization of 61 rifampin (RIF)-resistant Streptococ-
cus pneumoniae isolates revealed two isolates (Rif-15 and Rif-
16) of the Spain14-5 clone with identical recombinant rpoB
genes (5) that were collected at the Hospital Donostia (HD)
from two human immunodeficiency virus-infected patients.
Given that the Spain14-5 clone has been extensively studied in
HD (10, 11), we have analyzed in this work 10 RIF-susceptible
isolates representative of each pbp2b restriction fragment
length polymorphism allelic profile among 93 isolates of the
Spain14-5 clone from the HD (Table 1). The MICs, pulsed-
field gel electrophoresis patterns, and rpoB sequences were
determined as previously described (5). The two RIF-resistant
strains carried, in addition to the H499N change responsible
for RIF resistance (5), several residue changes common to five
RIF-susceptible isolates (Fig. 1) and to the Streptococcus mitis
NCTC 12261 type strain (5), changes that are therefore not
involved in RIF resistance. Comparisons of the rpoB sequences
of the 12 strains with that of S. pneumoniae R6 (Fig. 1) re-
vealed three types of isolates: four isolates that were nonre-
combinant (0.15% variation) whose sequences were identical
to that of the type strain, seven recombinant isolates (R2 and
R3; 4.1% variation) that had identical sequences (excluding
the mutation responsible for the H499N change), and one
recombinant isolate (R1; 1.2% variation) that featured two
blocks of divergence, the first (L42 to T472) being identical to
the sequence of S. pneumoniae R6 and the second (A473 to
T700) being identical to that of strains R2 and R3.
Recombination events between S. pneumoniae and the viri-
dans streptococci of the mitis group (VSM), which have pre-
sumably occurred in the face of antibiotic selection pressure
and have led to the acquisition of resistance, have been de-
scribed for the genes encoding the targets of penicillin (7),
fluoroquinolones (1, 4), and rifampin (5). Furthermore, re-
combination in genes not involved in antimicrobial resistance
and therefore not subjected to selective pressure has also been
detected (3, 8, 9). Given the great genetic diversity of neutral
VSM genes (12), fluoroquinolone target genes (1, 6), and rpoB
(M. J. Ferrándiz et al., unpublished), the most plausible expla-
nation for the identity of the sequences of the rpoB recombi-
nant isolates is that they derive from an ancestral isolate that
underwent recombination with an RIF-susceptible VSM at, or
before, 1987. Isolate Rif-16 would have acquired RIF resis-
tance by point mutation after recombination in the presence of
RIF selection (this patient had a Mycobacterium avium-dissem-
inated infection and was treated with RIF). Transmission
among patients infected with Rif-16 and Rif-15 could have
occurred, since there is no evidence of RIF treatment in the
patient infected with Rif-15 and both patients were admitted in
the same unit of HD. However, in other cases, RIF resistance
could be acquired directly by recombination (5), given that,
under the ideal laboratory conditions, the frequency of trans-
formation is several orders of magnitude greater than that of
spontaneous mutation, being 5  109 (2; our unpublished
results), and the frequencies of transformation are 1  102
(5) and 2  104 for chromosomal DNAs from S. pneumoniae
and VSM, respectively (data not shown). The frequency of
TABLE 1. Characteristics of S. pneumoniae isolates of the Spain14-5 clone from the Hospital Donostia
Isolatea Yr Origin Multilocus sequencetype Resistance pattern
b RIF MIC (g/ml) rpoB sequencec
ATCC 700902 18 P T C SxT 0.03
C-12950 1981 Pharynx 17 P E Cl TC 0.03 NR
C-54576 1990 Ear 18 P T C SxT 0.03 NR
H-9232-J 1995 Blood 18 P T C SxT 0.03 NR
E-232472 1999 Sputum 18 P T C SxT ClP 0.03 NR
E-234662 2002 Sputum 17 P E Cl T C SxT 0.03 R1
C-38500 1987 Ear 17 P E Cl T C SxT 0.03 R2
E-87-C 1991 Sputum 17 P E Cl T C SxT 0.03 R2
H-2728-H 1992 Blood 17 P E Cl T C SxT 0.03 R2
H-2950-L 1996 Blood 17 P E Cl T C SxT ClP 0.03 R2
E-232014 2001 Sputum 17 P E Cl T C SxT 0.03 R2
Rif-15 1993 Sputum 17 P E Cl T C SxT ClP R 16 R3
Rif-16 1993 Sputum 17 P E Cl T C SxT ClP R 16 R3
a ATCC 700902 is the strain representative of the Spain14-5 clone.
b P, resistant to penicillin (MICs, 2 g/ml); T, resistant to tetracycline (MICs, 4 g/ml); C, resistant to chloramphenicol (MICs, 8 g/ml); E, resistant to
erythromycin (MICs, 0.5 g/ml); Cl, resistant to clindamycin (MICs, 0.5 g/ml); SxT, resistant to trimethropin-sulfamethoxazole (MICs, 4 and 76 g/ml,
respectively); CIP, resistant to ciprofloxacin (MICs, 4 g/ml); R, resistant to RIF (MICs, 4 g/ml).
c NR, nonrecombinant; R1, R2 and R3, recombinant.
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transformation in the natural environment is presumably much
less than under laboratory conditions, given the low proportion
of recombinants among RIF-resistant isolates (5).
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6. González, I., M. Georgiou, F. Alcaide, D. Balas, J. Liñares, and A. G. de la
Campa. 1998. Fluoroquinolone resistance mutations in the parC, parE, and
gyrA genes of clinical isolates of viridans group streptococci. Antimicrob.
Agents Chemother. 42:2792–2798.
7. Hakenbeck, R., K. Kaminski, A. Köning, M. Van der Linden, J. Paik, P.
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